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Abstract text Background and Aims:  
The Very Early Rehabilitation of SpEech after stroke (VERSE) trial recently showed 
no benefit of more therapy (26 hours) compared to usual care (13 hours) delivered 
in the first 12 weeks of stroke recovery. This paper examines the question: What 
therapy frequency and session length is associated with recovery in 
individual aphasia therapy regimens in the first 12 weeks after stroke? 
Methods:  
Participants with aphasia, recruited from 17 Australia/New Zealand acute-stroke 
units were randomised to one of three treatment arms. This secondary analysis 
used linear mixed models to investigate the effects of therapy frequency and 
session length on the Western Aphasia Battery-Aphasia Quotient (AQ) at 12 
weeks, after controlling for therapy amount. 
Results:  
Participants (n=214) received aphasia therapy (mean=1377 minutes; sd=735) in 36 
sessions (sd=19) with mean session length: 39 minutes (sd=11) in the first 12 
weeks. The mean AQ was 41.2 (sd=28.0) at baseline and 67.7 (sd=29.5) at 12 
weeks. After controlling for baseline stroke and aphasia severity, site and therapy 
amount, the session length had a significant effect (b=0.33, p=0.024) of increasing 
AQ at 12 weeks by 0.33 points per minute increase in session length.  On average, 
1350 minutes of therapy provided in 30 sessions of 45 minutes each, can be 
expected to achieve 5 points more on AQ at 12 weeks, than if 45 sessions of 30 
minutes each was provided. 
Conclusions:  
Sessions of longer duration were associated with better recovery than a larger 
number of shorter sessions which achieved the same total amount of therapy. 
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